Sevoflurane

Generic Name
Sevoflurane
Brand Names
Sevorane, Sojourn, Ultane
Drug Type
Small Molecule
Chemical Formula
C4H3F7O
CAS Number
28523-86-6
Unique Ingredient Identifier
38LVP0K73A
Background

Sevoflurane is an ether inhalation anesthetic agent used to induce and maintain general anesthesia. It is a volatile, non-flammable compound with a low solubility profile and blood/gas partition coefficient. Sevoflurane was patented in 1972, was approved for clinical use in Japan in 1990, and approved by the FDA in 1996. Sevoflurane is three times more potent than desflurane, but has lower potency compared to halothane and isoflurane. Unlike other volatile anesthetics, sevoflurane has a pleasant odor and does not irritate the airway. The hemodynamic and respiratory depressive effects of sevoflurane are well tolerated, and most patients receiving this anesthetic agent present little toxicity. Therefore, it can be used for inhalational induction in adults and children for a wide variety of anesthetic procedures.

Indication

Sevoflurane is used for the induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery.

Associated Conditions
-
Associated Therapies
General Anesthesia, Induction and Maintenance of General Anesthesia
Clinical Trials
Related News

Anesthetic Effect on Immune Cell in Patients With Cancer

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Drug: propofol
Drug: Sevoflurane
First Posted Date
2016-05-02
Last Posted Date
2018-01-25
Lead Sponsor
Konkuk University Medical Center
Target Recruit Count
47
Registration Number
NCT02758249
Locations
🇰🇷

Konkuk University Medical Center, Seoul, Korea, Republic of

Nebulized Epoprostenol (FLOLAN) and Phenylephrine on One Lung Ventilation (OLV)

First Posted Date
2016-04-22
Last Posted Date
2019-05-17
Lead Sponsor
University Health Network, Toronto
Target Recruit Count
8
Registration Number
NCT02748265
Locations
🇨🇦

Toronto General Hospital, 200 Elizabeth St., Toronto, Ontario, Canada

Evaluation of Impact of Nitrous Oxide on PONV in Breast Surgeries

First Posted Date
2016-04-13
Last Posted Date
2017-04-26
Lead Sponsor
Tata Memorial Hospital
Target Recruit Count
250
Registration Number
NCT02736604
Locations
🇮🇳

Tata Memorial Hospital, Mumbai, Maharashtra, India

Volatile Anesthetic Protection Of Renal Transplants 2

First Posted Date
2016-04-04
Last Posted Date
2020-05-08
Lead Sponsor
Gertrude J. Nieuwenhuijs-Moeke
Target Recruit Count
488
Registration Number
NCT02727296
Locations
🇩🇰

Aarhus University Hospital, Aarhus, Denmark

🇪🇸

Fundagio Puigvert, Barcelona, Spain

🇳🇱

University Medical Center Groningen, Groningen, Netherlands

Decision Support for Intraoperative Low Blood Pressure

Not Applicable
Completed
Conditions
Hypotension
Interventions
Procedure: Attending real-time decision support
Procedure: In-room real-time decision support
Procedure: Attending feedback emails
Procedure: In-room provider feedback emails
Device: Anesthesia Information Management System (AIMS)
Device: Perioperative Data Warehouse (PDW)
Procedure: General anesthesia
Device: Pager system
Procedure: Central neuraxial anesthesia
Procedure: Non-cardiac surgery
Drug: Propofol
Drug: Sevoflurane
Drug: Desflurane
Drug: Isoflurane
Drug: Ephedrine
Drug: Phenylephrine
Drug: Norepinephrine
Drug: Epinephrine
Drug: Dobutamine
Drug: Dopamine
Drug: Isoproterenol
Drug: Milrinone
Drug: Atropine
Drug: Glycopyrrolate
Drug: Vasopressin
Drug: Terlipressin
Drug: Sodium Chloride 0.9%
Drug: Ringer's lactate
Drug: Hydroxyethyl starch solutions
Drug: Fresh Frozen Plasma
Drug: Packed Red Blood Cells
Drug: Albumin solutions
Drug: Plasma-Lyte
Drug: Lidocaine
Drug: Bupivacaine
Drug: Levobupivacaine
Drug: Ropivacaine
Drug: Mepivacaine
Drug: Tetracaine
Drug: Prilocaine
Drug: Procaine
Drug: Chloroprocaine
Drug: Benzocaine
Drug: Articaine
First Posted Date
2016-04-04
Last Posted Date
2019-05-16
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
22435
Registration Number
NCT02726620
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

The Effect of Anesthetics on Oxidative Stress and Apoptosis Status in Children

Not Applicable
Completed
Conditions
Anesthesia, General
Interventions
Drug: Sevoflurane
Drug: Propofol
First Posted Date
2016-03-17
Last Posted Date
2016-10-12
Lead Sponsor
First Affiliated Hospital, Sun Yat-Sen University
Target Recruit Count
47
Registration Number
NCT02711280
Locations
🇨🇳

The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China

Comparison of The Effects of Sevoflurane, Desflurane and Total Intravenous Anaesthesia on Pulmonary Function Tests

First Posted Date
2016-03-16
Last Posted Date
2016-03-16
Lead Sponsor
Istanbul University
Target Recruit Count
90
Registration Number
NCT02709863
Locations
🇹🇷

Istanbul University Cerrahpasa Medical Faculty Neurosurgery Department, Istanbul, Turkey

Recovery of Muscle Function After Deep Neuromuscular Block by Means of Diaphragm Ultrasonography

First Posted Date
2016-03-04
Last Posted Date
2016-10-25
Lead Sponsor
University of Florence
Target Recruit Count
58
Registration Number
NCT02698969
Locations
🇮🇹

Azienda Ospdaliero Universitaria Careggi, Florence, Italy

Comparison of Propofol and Sevoflurane as a Primary Anesthetic for Cardiac Ablation of Atrial Fibrillation.

Not Applicable
Completed
Conditions
Atrial Fibrillation
Interventions
Drug: sevoflurane
Drug: propofol
First Posted Date
2016-03-03
Last Posted Date
2024-08-20
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
135
Registration Number
NCT02697448
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

The Ratio of Hypnotic to Analgesic Potency of Volatile Anesthetics

Phase 3
Completed
Conditions
Anesthesia, General
Interventions
Drug: Sevoflurane
Drug: Desflurane
First Posted Date
2016-03-03
Last Posted Date
2018-05-08
Lead Sponsor
Kangbuk Samsung Hospital
Target Recruit Count
90
Registration Number
NCT02698514
Locations
🇰🇷

Kangbuk Samsung Hospital, Seoul, Korea, Republic of

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy